Kezar’s Lead Asset Bounces Back With Lupus Win

Following Myositis Setback

 
• By Ayisha Sharma
  
The Results Hit The Benchmark Touted By Some Analysts • Source: Shutterstock

More from Clinical Trials

More from R&D